A novel continuous yeast fermentation platform that enhances the production of citric acids, erythritol, and functional lipids. This platform offers higher product titer, rate, and yield compared to traditional batch processes, addressing key challenges in biomanufacturing.
The continuous yeast fermentation platform is designed to revolutionize the production of major fermentation products such as citric acids, erythritol, and functional lipids. Unlike traditional batch or fed-batch processes, this platform introduces a continuous bioreactor system that decouples cell growth and production phases. This innovation significantly enhances product titer, rate, and yield, making it a competitive alternative to petro-chemical manufacturing processes. The platform promises a robust, economical solution with potential applications in various industries requiring efficient biomanufacturing.
The platform is currently at Technology Readiness Level 4, indicating that it has been validated in a laboratory environment. Future plans include optimizing media and process conditions, developing continuous fermentation systems for increased production metrics, and transferring the technology to industry partners through collaborative efforts.
UMass Lowell is a comprehensive public research university in the University of Massachusetts system, known for hands-on, industry-aligned education. Industry partners engage through open-access core research facilities and pilot-scale labs for prototyping and scale-up, supported by staff for contract services. A robust co-op program connects companies with student and faculty talent, while incubator and coworking sites near campus offer labs and flexible space. Research is supported by competitive federal funding from agencies such as the National Science Foundation, National Institutes of Health, Department of Energy, and Department of Defense. A dedicated technology transfer office supports IP, licensing, sponsored research, and startup formation to streamline commercialization.